RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CRNX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

A very strong day for Crinetics Pharmaceuticals Inc stock price on Thursday
(Updated on Mar 28, 2024)

Buy candidate since Mar 19, 2024 Gain 3.61% PDF

The Crinetics Pharmaceuticals Inc stock price gained 5.36% on the last trading day (Thursday, 28th Mar 2024), rising from $44.43 to $46.81. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 7.16% from a day low at $44.01 to a day high of $47.16. The price has risen in 6 of the last 10 days and is up by 22.51% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 466 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $60.34 million.

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 22.21% during the next 3 months and, with a 90% probability hold a price between $47.77 and $59.63 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CRNX Signals & Forecast

The Crinetics Pharmaceuticals Inc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $44.64 and $40.88. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday, March 18, 2024, and so far it has risen 23.41%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Crinetics Pharmaceuticals Inc stock

Crinetics Pharmaceuticals Inc finds support from accumulated volume at $45.18 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $3.15 between high and low, or 7.16%. For the last week, the stock has had daily average volatility of 4.48%.

Our recommended stop-loss: $45.05 (-3.76%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 8 days ago.)

Trading Expectations (CRNX) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Crinetics Pharmaceuticals Inc to open at $45.99, and during the day (based on 14 day Average True Range), to move between $44.38 and $49.24, which gives a possible trading interval of +/-$2.43 (+/-5.18%) up or down from last closing price. If Crinetics Pharmaceuticals Inc takes out the full calculated possible swing range there will be an estimated 10.37% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $45.18, some $1.63 (3.48%) from the current price of $46.81, our system finds the risk reward attractive.

Is Crinetics Pharmaceuticals Inc stock A Buy?

Crinetics Pharmaceuticals Inc holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Buy candidate.

Current score: 6.617 Strong Buy Candidate Upgraded

Predicted Opening Price for Crinetics Pharmaceuticals Inc of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$45.99 ( 1.74%) $46.81

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CRNX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 49.14 4.98 %
R2 47.94 2.41 %
R1 47.20 0.83 %
Current price: 46.81
Support S1 44.79 -4.32 %
S2 44.05 -5.90 %
S3 42.84 -8.47 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 46.81
Support S1 45.18 -3.48%
S2 42.76 -8.65%
S3 37.82 -19.21%

FAQ

What is the symbol for Crinetics Pharmaceuticals Inc Stock and on which exchange is it traded?
The symbol for Crinetics Pharmaceuticals Inc is CRNX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Crinetics Pharmaceuticals Inc Stock?
Crinetics Pharmaceuticals Inc holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Buy candidate.

How to buy Crinetics Pharmaceuticals Inc Stock?
Crinetics Pharmaceuticals Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Crinetics Pharmaceuticals Inc Stock.

What's the current price of Crinetics Pharmaceuticals Inc Stock?
As of the end of day on the 2024-03-28, the price of an Crinetics Pharmaceuticals Inc (CRNX) share was $46.81.

What is the 52-week high and low for Crinetics Pharmaceuticals Inc Stock?
The 52-week high for Crinetics Pharmaceuticals Inc Stock is $47.58 and the 52-week low is $15.36.

What is the market capitalization of Crinetics Pharmaceuticals Inc Stock?
As of the 2024-03-28, the market capitalization of Crinetics Pharmaceuticals Inc is 3.38B.

When is the next earnings date for Crinetics Pharmaceuticals Inc?
The upcoming earnings date for Crinetics Pharmaceuticals Inc is May 02, 2024.
Click to get the best stock tips daily for free!

About Crinetics Pharmaceuticals Inc

Crinetics Pharmaceuticals Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III clinical trial for the treatment of acromegaly, as well as completed phase II clinical trial to treat c... CRNX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT